Inventor · disambiguated record
Wenge Zhong
Also filed as: ZHONG WENGE
36 granted patents·23 pending applications·153 citations·filing 2003–2025
97Inventor score
Top patents by PatentIndex Score
59 records- 0197US10954221B2GLP-1R agonists and uses thereofQILU REGOR THERAPEUTICS INC·Filed 2020·Granted Mar 23, 2021·14 cites·4 claims
- 0297US10844049B2GLP-1R agonists and uses thereofQILU REGOR THERAPEUTICS INC·Filed 2020·Granted Nov 24, 2020·15 cites·32 claims
- 0393US11591321B2GLP-1R agonists and uses thereofQILU REGOR THERAPEUTICS INC·Filed 2020·Granted Feb 28, 2023·3 cites·28 claims
- 0490US9718803B2Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2015·Granted Aug 1, 2017·8 cites·19 claims
- 0590US8957073B2Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitorsALLEN JENNIFER R·Filed 2011·Granted Feb 17, 2015·15 cites·31 claims
- 0688US2025064806A1Cdk inhibitorsREGOR PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0786US7872009B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jan 18, 2011·11 cites·8 claims
- 0886US2025275972A1Cdk inhibitorsGENENTECH INC·Filed 2025·Application pending·0 cites
- 0986US2025275971A1Cdk inhibitorsGENENTECH INC·Filed 2025·Application pending·0 cites
- 1086US2025325544A1Cdk inhibitorsGENENTECH INC·Filed 2025·Application pending·0 cites
- 1186US2025281487A1Cdk inhibitorsGENENTECH INC·Filed 2025·Application pending·0 cites
- 1285US12365670B2GLP-IR agonists and uses thereofQILU REGOR THERAPEUTICS INC·Filed 2019·Granted Jul 22, 2025·2 cites·25 claims
- 1385US6822097B1Compounds and methods of usesAMGEN INC·Filed 2003·Granted Nov 23, 2004·23 cites·44 claims
- 1485US2024066031A1Cdk inhibitorsQILU REGOR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1585US2024033264A1Cdk inhibitorsQILU REGOR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1684US9296698B2Amino heteroaryl compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2010·Granted Mar 29, 2016·5 cites·14 claims
- 1782US9303028B2Azetidine and piperidine compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2014·Granted Apr 5, 2016·4 cites·18 claims
- 1882US9096527B2TRPM8 antagonists and their use in treatmentsAMGEN INC·Filed 2014·Granted Aug 4, 2015·5 cites·38 claims
- 1981US8957083B2Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of useMINATTI ANA ELENA·Filed 2011·Granted Feb 17, 2015·4 cites·19 claims
- 2081US8921363B2Derivatives of 1 H-isoindol-3-amine, 1 H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as beta-secretase inhibitorsMINATTI ANA ELENA·Filed 2011·Granted Dec 30, 2014·4 cites·7 claims
- 2180US9556135B2Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of useAMGEN INC·Filed 2013·Granted Jan 31, 2017·2 cites·38 claims
- 2280US9012446B2Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2013·Granted Apr 21, 2015·4 cites·20 claims
- 2380US8691986B2Azetidine and piperidine compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2013·Granted Apr 8, 2014·3 cites·8 claims
- 2479US12285429B2CDK inhibitorsGENENTECH INC·Filed 2021·Granted Apr 29, 2025·0 cites·12 claims
- 2578US9174992B2Heterobicyclic compoundsAMGEN INC·Filed 2013·Granted Nov 3, 2015·4 cites·17 claims
- 2678US8497264B2Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useCHEN JIAN J·Filed 2011·Granted Jul 30, 2013·4 cites·29 claims
- 2777US7745484B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jun 29, 2010·2 cites·15 claims
- 2877US7119111B22-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of useAMGEN INC·Filed 2003·Granted Oct 10, 2006·11 cites·24 claims
- 2976US8883782B2Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2011·Granted Nov 11, 2014·4 cites·18 claims
- 3076US2025042883A1Glp-1r agonists and uses thereofQILU REGOR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3173US9296734B2Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2014·Granted Mar 29, 2016·2 cites·39 claims
- 3272US7973047B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2010·Granted Jul 5, 2011·2 cites·21 claims
- 3372US2022296595A1Cdk inhibitorsQILU REGOR THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3471US2023278991A1Glp-1r agonists and uses thereofQILU REGOR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3570US8778941B2TRPM8 antagonists and their use in treatmentsBROWN JAMES·Filed 2012·Granted Jul 15, 2014·1 cites·33 claims
- 3670US7838676B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Nov 23, 2010·1 cites·11 claims
- 3764US7803809B2Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2008·Granted Sep 28, 2010·0 cites·9 claims
- 3862US2023339896A1Hpk1 inhibitors and uses thereofQILU REGOR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3960US8163909B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2008·Granted Apr 24, 2012·0 cites·17 claims
- 4060US2025136607A1Pad4 inhibitors and use thereofREGOR PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4158US2014107109A1Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of useAMGEN INC·Filed 2013·Application pending·0 cites
- 4258US2022389037A1Hpk1 inhibitors and uses thereofQILU REGOR THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4357US9493459B2Azetidine and piperidine compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2016·Granted Nov 15, 2016·0 cites·3 claims
- 4457US2014213572A1Unsaturated nitrogen heterocyclic compounds useful as pde10 inhibitorsAMGEN INC·Filed 2014·Application pending·0 cites
- 4556US8173810B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2008·Granted May 8, 2012·0 cites·17 claims
- 4656US2024002368A1Sting antagonists and uses thereofQILU REGOR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4756US2006241151A1Pyrid-2-one derivatives and methods of useAMGEN INC·Filed 2006·Application pending·0 cites
- 4854US2024051956A1Sos1 inhibitors and uses thereofQILU REGOR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4952US2007032518A1Compounds and methods of useAMGEN INC·Filed 2004·Application pending·0 cites
- 5052US2014235642A1Trpm8 antagonists and their use in treatmentsAMGEN INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wenge Zhong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →